ABSTRACT
INTRODUCTION

47
Chlamydia pneumoniae is an obligate intracellular bacterium and a causative agent of 48 respiratory tract infections including community-acquired pneumonia (1, 2) . The 49 seroprevalence rates of C. pneumoniae infection, which start to rise relatively early in 50 childhood, are increased by 50% at 20 years of age, and subsequently reach 70-80% by 60-51 70 years (3, 4), suggesting most individuals will have had some exposure to the bacteria in 52 their lifetime. Therefore, C. pneumoniae is likely a ubiquitous pathogen in individuals 53 worldwide (4). The symptoms of pulmonary infection vary considerably according to age 54 from asymptomatic or mild illness to serious pneumonia, especially in pediatric infection 3). Regarding this, several studies indicate that bacterial infection might exacerbate 56 pulmonary inflammation, and thus is associated with a more serious chronic disease, asthma 57 (3). The proinflammatory cytokine interleukin (IL)-1β, which is induced by C. pneumoniae 58 (5-8), is thought to play a critical role in the development of chronic inflammatory disease,
59
although detailed mechanisms remain unclear. Air pollution containing carbon nanoparticles, 60 environmental air contaminants that might be easily inhaled with C. pneumoniae, also appear 61 to be a critical factor in the pathogenesis of asthma (9) (10) (11) . Recent studies indicated that 62 carbon black or carbon nanotubes (CNTs), belonging to carbon nanoparticles, stimulate IL-1β 
81
In the present study, we assessed whether co-stimulation of C. pneumoniae with CNTs 
MATERIALS AND METHODS
86
Chemical reagents. Phorbol 12-myristate 13-acetate (PMA), Escherichia coli LPS 87 (O55:B5), ATP, and N-acetyl-L-cysteine (NAC) were purchased from Sigma-Aldrich (St.
88
Louis, MO). Pan-caspase inhibitor, Z-VAD-FMK and caspase-1 inhibitor, Z-WHED-FMK,
89
were also purchased from Peptide Institute (Osaka, Japan) and Enzo Life Sciences Bacteria. C. pneumoniae TW183 was used in this study. The bacteria were 100 propagated in HEp-2 cells as described previously (21). Infected cells were collected after 3 101 days incubation and then disrupted by freeze-thawing. After brief centrifugation at 180 × g 102 for 5 min to remove cell debris, bacteria were concentrated at 9,000 × g for 10 min at 4 °C.
103
Bacterial pellets were resuspended in sucrose-phosphate-glutamic acid buffer and stored at for Chlamydia LPS (Denka Seiken, Tokyo, Japan) as described previously (21).
108
CNTs. Single-wall CNTs 1.1 nm in diameter and 2,000-5,000 nm in length (Carbon 109 Nanotechnologies Inc., TX., USA), were used as carbon nanoparticles in this study. CNTs
110
were suspended in distilled water according to the method described previously (22) processed for alcohol dehydration and embedding in Epon 813, as described previously (21).
167
Ultrathin sections of the cells were stained with lead citrate and uranium acetate before being 168 viewed by electron microscopy. CNTs (Fig. 3A) . The addition of chloramphenicol to the cultures had no influence on the 
245
As expected, IL-18 secretion was significantly enhanced when incubated under combination 246 of C. pneumoniae with CNTs (Fig. 6A) . Furthermore, it was also confirmed that the IL-18 247 secretion was increased in a time-dependent manner (Fig. 6B) , . In addition, IL-18 and that 248 the secretion as well as IL-1β maturation was significantly inhibited in a dose-dependent 249 manner of the caspase-1 inhibitor (Fig. 6C) . Thus, the results were supported by the evidence CNTs (Fig. 7B) with NaCl (control), indicating a requirement of K + efflux (Fig. 8A) . In addition, treatment
274
with CA-074 Me obviously blocked IL-1β secretion, indicating that IL-1β secretion requires 275 lysosomal degradation (Fig. 8B) . Furthermore, treatment with DPI, but not NAC, inhibited
276
IL-1β secretion, indicating IL-1β secretion partially requires ROS generation (Fig. 8C) .
277
Together, the results suggested that NLRP3 inflammasome activation coincidently requires 278 three distinct upstream signals, K + efflux, lysosomal degradation, and ROS production. such as asthma (3), which is evoked by air pollution containing carbon nanoparticles (9-11).
288
However, the detailed mechanisms by which C. pneumoniae is involved in the development 289 of asthma still remain unclear. We therefore studied the synergistic effect of C. pneumoniae 290 with carbon nanoparticle derivatives, CNTs, on IL-1β secretion, to determine whether it 291 exacerbated the mechanisms involved in C. pneumoniae infection. We found that CNTs 292 synergistically enhanced IL-1β secretion from C. pneumoniae-infected macrophages.
293
In contrast to treatment with polymer such as dextran that enhances chlamydial 
323
The current study indicates that full caspase-1 activation is important for C. pneumoniae-infected cells with CNTs treatment might occur in an ASC-independent manner, 334 although further study is required to clarify this.
335
In conclusion, this study showed that CNTs synergistically activate the NLRP3 IL-1β secretion from C. pneumoniae-infected cells with CNT treatment (Fig. 9 ). While C. 
